A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
Clinical trial NCT03037203 · COMPLETED
Trial details
- NCT number
- NCT03037203
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-08-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.